文献速递男科与性医学

实体器官移植受者中的阴茎假体:匹配队列研究

Penile Prosthesis in Solid Organ Transplant Recipients-A Matched Cohort Study.
PubMed 文献 · Urology · 2018-04-12

该回顾性匹配队列研究比较了26例实体器官移植(SOT)后接受可膨胀阴茎假体(IPP)植入的患者与26例年龄匹配的非移植对照。结果显示两组IPP再手术率均为11.5%(P=1.00),无显著差异,且再手术率不因移植器官或假体型号(2件套 vs 3件套)而异。结论认为SOT患者IPP植入结局与非移植患者相似,应考虑为合适候选者。

要点

  • SOT患者IPP再手术率与非移植对照无显著差异(11.5% vs 11.5%,P=1.00)。
  • 再手术率不因移植器官类型或2件套 vs 3件套假体型号而异(P=1.00;P=.47)。
  • SOT患者外周血管病、卒中和糖尿病更常见,但未影响IPP再手术率。

核心结论

  • SOT患者IPP植入的再手术结局与非移植患者相似,应视为阴茎假体的合适候选者。

研究设计与样本

  • 回顾性匹配队列研究,纳入1999至2015年单中心26例SOT后行IPP植入患者,以26例年龄匹配的非SOT IPP受者为对照。

主要发现

  • SOT组与对照组IPP再手术率均为11.5%(P=1.00)。
  • 再手术率在不同移植器官间无差异(P=1.00),2件套与3件套IPP间也无差异(P=.47)。
  • SOT组外周血管病(26.9% vs 3.9%,P=.021)、卒中(19.2% vs 0.0%,P=.05)和糖尿病(84.6% vs 53.6%,P=.016)更常见。
  • 两组年龄(53.7±8.1 vs 56.4±9.0,P=.26)、BMI(30.3±5.5 vs 30.2±4.7,P=.92)及前列腺切除史(7.7% vs 15.4%,P=.39)等无显著差异。

临床怎么用

  • SOT患者在接受IPP植入前无需因移植状态本身而排除,但需注意其外周血管病、卒中和糖尿病合并症负担较高。

局限性

  • 回顾性单中心设计,样本量较小(SOT组26例,对照组26例),随访时间两组不一致(SOT组29.5个月 vs 对照组13.5个月)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether patients with solid organ transplant (SOT) are at higher risk of developing complications after inflatable penile prosthesis (IPP) implantation. METHODS: We retrospectively reviewed outcomes data for all patients with SOT who underwent IPP placement at our institution. A cohort of age-matched IPP recipients without SOT were used as controls. RESULTS: We identified 26 patients who underwent SOT and IPP between 1999 and 2015, and 26 controls. Transplants included heart (3), liver (2), kidney only (17), and kidney and pancreas (4). Mean follow-up time after IPP placement was 29.5 months (SOT group) and 13.5 months (controls). Age at IPP did not significantly differ between groups (53.7 + 8.1 vs 56.4 + 9.0, P = .26), nor did body mass index (30.3 + 5.5 vs 30.2 + 4.7, P = .92), history of prostatectomy (7.7% vs 15.4%, P = .39), rectal surgery (3.9% vs 3.9%, P = 1.00), hyperlipidemia (69.2% vs 69.2%, P = 1.00), hypertension (92.3% vs 76.9%, P = .25), or heart disease (57.7% vs 30.8%, P = .093). Peripheral vascular disease was more common in transplant patients (26.9% vs 3.9%, P = .021), as were stroke (19.2% vs 0.0%, P = .05) and diabetes (84.6% vs 53.6%, P = .016). No significant differences in IPP reoperation rates existed between patients with vs without SOT (11.5% vs 11.5%, P = 1.00), nor did they differ by organ transplanted (P = 1.00). No differences in IPP reoperation rate existed between 2-piece vs 3-piece IPP models (P = .47). CONCLUSION: Outcomes of IPP implantation in patients with SOT are similar to those of nontransplant patients. Patients with SOT should be considered suitable candidates for penile prosthesis.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Sun AY, Babbar P, Gill BC, et al. Penile Prosthesis in Solid Organ Transplant Recipients-A Matched Cohort Study. Urology. 2018. PMID: 29656065. doi:10.1016/j.urology.2018.03.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。